Acuta Capital Partners’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-101,050	Closed	-$1.02M	–	54
2014 Q4	$1.02M	Buy	+101,050	New	+$1.02M	0.69%	38